nodes	percent_of_prediction	percent_of_DWPC	metapath
Dihydroxyaluminium—VDAC1—Mitochondrial protein import—TOMM40—Alzheimer's disease	0.0411	0.277	CbGpPWpGaD
Dihydroxyaluminium—VDAC1—Mitochondrial protein import—ATP5A1—Alzheimer's disease	0.0366	0.247	CbGpPWpGaD
Dihydroxyaluminium—VDAC2—forebrain—Alzheimer's disease	0.0319	0.0974	CbGeAlD
Dihydroxyaluminium—Pulmonary congestion—Donepezil—Alzheimer's disease	0.0308	0.0588	CcSEcCtD
Dihydroxyaluminium—VDAC2—telencephalon—Alzheimer's disease	0.0294	0.0896	CbGeAlD
Dihydroxyaluminium—VDAC3—forebrain—Alzheimer's disease	0.0266	0.0811	CbGeAlD
Dihydroxyaluminium—Respiratory tract congestion—Donepezil—Alzheimer's disease	0.0255	0.0486	CcSEcCtD
Dihydroxyaluminium—VDAC1—forebrain—Alzheimer's disease	0.0253	0.0772	CbGeAlD
Dihydroxyaluminium—VDAC3—telencephalon—Alzheimer's disease	0.0245	0.0746	CbGeAlD
Dihydroxyaluminium—VDAC1—telencephalon—Alzheimer's disease	0.0233	0.071	CbGeAlD
Dihydroxyaluminium—VDAC1—Mitochondrial protein import—HSPD1—Alzheimer's disease	0.0189	0.127	CbGpPWpGaD
Dihydroxyaluminium—VDAC2—nervous system—Alzheimer's disease	0.0173	0.0529	CbGeAlD
Dihydroxyaluminium—VDAC2—central nervous system—Alzheimer's disease	0.0167	0.0509	CbGeAlD
Dihydroxyaluminium—VDAC2—cerebellum—Alzheimer's disease	0.0163	0.0498	CbGeAlD
Dihydroxyaluminium—Venous thrombosis—Memantine—Alzheimer's disease	0.0156	0.0299	CcSEcCtD
Dihydroxyaluminium—VDAC3—nervous system—Alzheimer's disease	0.0144	0.044	CbGeAlD
Dihydroxyaluminium—VDAC3—central nervous system—Alzheimer's disease	0.0139	0.0424	CbGeAlD
Dihydroxyaluminium—VDAC1—nervous system—Alzheimer's disease	0.0137	0.0419	CbGeAlD
Dihydroxyaluminium—VDAC3—cerebellum—Alzheimer's disease	0.0136	0.0414	CbGeAlD
Dihydroxyaluminium—VDAC2—brain—Alzheimer's disease	0.0132	0.0404	CbGeAlD
Dihydroxyaluminium—VDAC1—central nervous system—Alzheimer's disease	0.0132	0.0403	CbGeAlD
Dihydroxyaluminium—Encephalopathy—Memantine—Alzheimer's disease	0.0132	0.0251	CcSEcCtD
Dihydroxyaluminium—VDAC1—cerebellum—Alzheimer's disease	0.0129	0.0394	CbGeAlD
Dihydroxyaluminium—Lung disorder—Rivastigmine—Alzheimer's disease	0.0117	0.0223	CcSEcCtD
Dihydroxyaluminium—Salivary hypersecretion—Galantamine—Alzheimer's disease	0.0117	0.0222	CcSEcCtD
Dihydroxyaluminium—VDAC3—brain—Alzheimer's disease	0.011	0.0337	CbGeAlD
Dihydroxyaluminium—VDAC1—brain—Alzheimer's disease	0.0105	0.032	CbGeAlD
Dihydroxyaluminium—Cardiovascular disorder—Memantine—Alzheimer's disease	0.00961	0.0183	CcSEcCtD
Dihydroxyaluminium—Cardiovascular disorder—Rivastigmine—Alzheimer's disease	0.0094	0.0179	CcSEcCtD
Dihydroxyaluminium—Salivary hypersecretion—Donepezil—Alzheimer's disease	0.00903	0.0172	CcSEcCtD
Dihydroxyaluminium—Urinary retention—Galantamine—Alzheimer's disease	0.00828	0.0158	CcSEcCtD
Dihydroxyaluminium—Dehydration—Galantamine—Alzheimer's disease	0.0081	0.0155	CcSEcCtD
Dihydroxyaluminium—Salivary hypersecretion—Rivastigmine—Alzheimer's disease	0.00802	0.0153	CcSEcCtD
Dihydroxyaluminium—Coma—Memantine—Alzheimer's disease	0.00772	0.0147	CcSEcCtD
Dihydroxyaluminium—Coma—Rivastigmine—Alzheimer's disease	0.00755	0.0144	CcSEcCtD
Dihydroxyaluminium—Phlebitis—Memantine—Alzheimer's disease	0.00712	0.0136	CcSEcCtD
Dihydroxyaluminium—Thirst—Donepezil—Alzheimer's disease	0.00709	0.0135	CcSEcCtD
Dihydroxyaluminium—Thrombophlebitis—Memantine—Alzheimer's disease	0.00708	0.0135	CcSEcCtD
Dihydroxyaluminium—Polyuria—Memantine—Alzheimer's disease	0.00698	0.0133	CcSEcCtD
Dihydroxyaluminium—Phlebitis—Rivastigmine—Alzheimer's disease	0.00696	0.0133	CcSEcCtD
Dihydroxyaluminium—Thrombophlebitis—Rivastigmine—Alzheimer's disease	0.00693	0.0132	CcSEcCtD
Dihydroxyaluminium—Polyuria—Rivastigmine—Alzheimer's disease	0.00683	0.013	CcSEcCtD
Dihydroxyaluminium—Hyponatraemia—Donepezil—Alzheimer's disease	0.00678	0.0129	CcSEcCtD
Dihydroxyaluminium—Urinary retention—Donepezil—Alzheimer's disease	0.00642	0.0123	CcSEcCtD
Dihydroxyaluminium—Thirst—Rivastigmine—Alzheimer's disease	0.0063	0.012	CcSEcCtD
Dihydroxyaluminium—Dehydration—Donepezil—Alzheimer's disease	0.00628	0.012	CcSEcCtD
Dihydroxyaluminium—Hyponatraemia—Memantine—Alzheimer's disease	0.00616	0.0117	CcSEcCtD
Dihydroxyaluminium—Rhinitis—Galantamine—Alzheimer's disease	0.00604	0.0115	CcSEcCtD
Dihydroxyaluminium—Hyponatraemia—Rivastigmine—Alzheimer's disease	0.00602	0.0115	CcSEcCtD
Dihydroxyaluminium—Urinary retention—Memantine—Alzheimer's disease	0.00583	0.0111	CcSEcCtD
Dihydroxyaluminium—Visual impairment—Galantamine—Alzheimer's disease	0.00581	0.0111	CcSEcCtD
Dihydroxyaluminium—Urinary retention—Rivastigmine—Alzheimer's disease	0.0057	0.0109	CcSEcCtD
Dihydroxyaluminium—Dehydration—Memantine—Alzheimer's disease	0.0057	0.0109	CcSEcCtD
Dihydroxyaluminium—Angina pectoris—Donepezil—Alzheimer's disease	0.00568	0.0108	CcSEcCtD
Dihydroxyaluminium—Dehydration—Rivastigmine—Alzheimer's disease	0.00558	0.0106	CcSEcCtD
Dihydroxyaluminium—VDAC1—Metabolism of proteins—TOMM40—Alzheimer's disease	0.00523	0.0353	CbGpPWpGaD
Dihydroxyaluminium—Angina pectoris—Memantine—Alzheimer's disease	0.00516	0.00985	CcSEcCtD
Dihydroxyaluminium—Back pain—Galantamine—Alzheimer's disease	0.00508	0.00968	CcSEcCtD
Dihydroxyaluminium—Angina pectoris—Rivastigmine—Alzheimer's disease	0.00505	0.00963	CcSEcCtD
Dihydroxyaluminium—Vision blurred—Galantamine—Alzheimer's disease	0.00494	0.00943	CcSEcCtD
Dihydroxyaluminium—VDAC1—Metabolism of proteins—ADAMTS2—Alzheimer's disease	0.00492	0.0332	CbGpPWpGaD
Dihydroxyaluminium—Vertigo—Galantamine—Alzheimer's disease	0.00471	0.00899	CcSEcCtD
Dihydroxyaluminium—Rhinitis—Donepezil—Alzheimer's disease	0.00468	0.00894	CcSEcCtD
Dihydroxyaluminium—VDAC1—Metabolism of proteins—ATP5A1—Alzheimer's disease	0.00466	0.0315	CbGpPWpGaD
Dihydroxyaluminium—Convulsion—Galantamine—Alzheimer's disease	0.00455	0.00867	CcSEcCtD
Dihydroxyaluminium—Visual impairment—Donepezil—Alzheimer's disease	0.0045	0.00859	CcSEcCtD
Dihydroxyaluminium—VDAC1—Metabolism of proteins—SLC30A6—Alzheimer's disease	0.00427	0.0288	CbGpPWpGaD
Dihydroxyaluminium—Rhinitis—Memantine—Alzheimer's disease	0.00425	0.00811	CcSEcCtD
Dihydroxyaluminium—Chills—Donepezil—Alzheimer's disease	0.00419	0.008	CcSEcCtD
Dihydroxyaluminium—Tachycardia—Galantamine—Alzheimer's disease	0.00418	0.00797	CcSEcCtD
Dihydroxyaluminium—Rhinitis—Rivastigmine—Alzheimer's disease	0.00416	0.00794	CcSEcCtD
Dihydroxyaluminium—Visual impairment—Memantine—Alzheimer's disease	0.00409	0.0078	CcSEcCtD
Dihydroxyaluminium—Hypotension—Galantamine—Alzheimer's disease	0.004	0.00763	CcSEcCtD
Dihydroxyaluminium—Visual impairment—Rivastigmine—Alzheimer's disease	0.004	0.00763	CcSEcCtD
Dihydroxyaluminium—VDAC1—Metabolism of proteins—TPP1—Alzheimer's disease	0.00397	0.0268	CbGpPWpGaD
Dihydroxyaluminium—Back pain—Donepezil—Alzheimer's disease	0.00393	0.0075	CcSEcCtD
Dihydroxyaluminium—Vision blurred—Donepezil—Alzheimer's disease	0.00383	0.00731	CcSEcCtD
Dihydroxyaluminium—Chills—Memantine—Alzheimer's disease	0.00381	0.00726	CcSEcCtD
Dihydroxyaluminium—Chills—Rivastigmine—Alzheimer's disease	0.00372	0.0071	CcSEcCtD
Dihydroxyaluminium—Vertigo—Donepezil—Alzheimer's disease	0.00365	0.00697	CcSEcCtD
Dihydroxyaluminium—Back pain—Memantine—Alzheimer's disease	0.00357	0.00681	CcSEcCtD
Dihydroxyaluminium—Convulsion—Donepezil—Alzheimer's disease	0.00352	0.00672	CcSEcCtD
Dihydroxyaluminium—Back pain—Rivastigmine—Alzheimer's disease	0.00349	0.00667	CcSEcCtD
Dihydroxyaluminium—Vision blurred—Memantine—Alzheimer's disease	0.00348	0.00664	CcSEcCtD
Dihydroxyaluminium—Vision blurred—Rivastigmine—Alzheimer's disease	0.0034	0.00649	CcSEcCtD
Dihydroxyaluminium—Body temperature increased—Galantamine—Alzheimer's disease	0.00339	0.00646	CcSEcCtD
Dihydroxyaluminium—Oedema—Donepezil—Alzheimer's disease	0.00332	0.00633	CcSEcCtD
Dihydroxyaluminium—Vertigo—Memantine—Alzheimer's disease	0.00332	0.00633	CcSEcCtD
Dihydroxyaluminium—TNNC1—Muscle contraction—CALM1—Alzheimer's disease	0.00331	0.0223	CbGpPWpGaD
Dihydroxyaluminium—Infection—Donepezil—Alzheimer's disease	0.0033	0.00629	CcSEcCtD
Dihydroxyaluminium—Vertigo—Rivastigmine—Alzheimer's disease	0.00325	0.00619	CcSEcCtD
Dihydroxyaluminium—Convulsion—Memantine—Alzheimer's disease	0.0032	0.0061	CcSEcCtD
Dihydroxyaluminium—VDAC1—Metabolism of proteins—ADAMTS4—Alzheimer's disease	0.00317	0.0214	CbGpPWpGaD
Dihydroxyaluminium—Hypersensitivity—Galantamine—Alzheimer's disease	0.00315	0.00602	CcSEcCtD
Dihydroxyaluminium—Convulsion—Rivastigmine—Alzheimer's disease	0.00313	0.00597	CcSEcCtD
Dihydroxyaluminium—Hypotension—Donepezil—Alzheimer's disease	0.0031	0.00592	CcSEcCtD
Dihydroxyaluminium—Oedema—Memantine—Alzheimer's disease	0.00301	0.00575	CcSEcCtD
Dihydroxyaluminium—Infection—Memantine—Alzheimer's disease	0.00299	0.00571	CcSEcCtD
Dihydroxyaluminium—Oedema—Rivastigmine—Alzheimer's disease	0.00295	0.00562	CcSEcCtD
Dihydroxyaluminium—Tachycardia—Memantine—Alzheimer's disease	0.00294	0.00561	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Galantamine—Alzheimer's disease	0.00293	0.00559	CcSEcCtD
Dihydroxyaluminium—Infection—Rivastigmine—Alzheimer's disease	0.00293	0.00559	CcSEcCtD
Dihydroxyaluminium—Tachycardia—Rivastigmine—Alzheimer's disease	0.00288	0.00549	CcSEcCtD
Dihydroxyaluminium—Pain—Donepezil—Alzheimer's disease	0.00284	0.00541	CcSEcCtD
Dihydroxyaluminium—Dizziness—Galantamine—Alzheimer's disease	0.00283	0.0054	CcSEcCtD
Dihydroxyaluminium—Hypotension—Memantine—Alzheimer's disease	0.00282	0.00537	CcSEcCtD
Dihydroxyaluminium—Hypotension—Rivastigmine—Alzheimer's disease	0.00275	0.00526	CcSEcCtD
Dihydroxyaluminium—Vomiting—Galantamine—Alzheimer's disease	0.00272	0.00519	CcSEcCtD
Dihydroxyaluminium—Urticaria—Donepezil—Alzheimer's disease	0.00264	0.00503	CcSEcCtD
Dihydroxyaluminium—Body temperature increased—Donepezil—Alzheimer's disease	0.00262	0.00501	CcSEcCtD
Dihydroxyaluminium—VDAC1—Metabolism of proteins—MME—Alzheimer's disease	0.00258	0.0175	CbGpPWpGaD
Dihydroxyaluminium—Pain—Memantine—Alzheimer's disease	0.00258	0.00492	CcSEcCtD
Dihydroxyaluminium—Nausea—Galantamine—Alzheimer's disease	0.00254	0.00485	CcSEcCtD
Dihydroxyaluminium—Pain—Rivastigmine—Alzheimer's disease	0.00252	0.00481	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Donepezil—Alzheimer's disease	0.00245	0.00467	CcSEcCtD
Dihydroxyaluminium—VDAC1—Metabolism of proteins—HSPD1—Alzheimer's disease	0.0024	0.0162	CbGpPWpGaD
Dihydroxyaluminium—Urticaria—Memantine—Alzheimer's disease	0.00239	0.00457	CcSEcCtD
Dihydroxyaluminium—Body temperature increased—Memantine—Alzheimer's disease	0.00238	0.00454	CcSEcCtD
Dihydroxyaluminium—Urticaria—Rivastigmine—Alzheimer's disease	0.00234	0.00447	CcSEcCtD
Dihydroxyaluminium—Body temperature increased—Rivastigmine—Alzheimer's disease	0.00233	0.00445	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Donepezil—Alzheimer's disease	0.00227	0.00433	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Memantine—Alzheimer's disease	0.00222	0.00424	CcSEcCtD
Dihydroxyaluminium—Dizziness—Donepezil—Alzheimer's disease	0.00219	0.00419	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.00217	0.00414	CcSEcCtD
Dihydroxyaluminium—Vomiting—Donepezil—Alzheimer's disease	0.00211	0.00403	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Memantine—Alzheimer's disease	0.00206	0.00393	CcSEcCtD
Dihydroxyaluminium—VDAC1—Metabolism of proteins—EIF2S1—Alzheimer's disease	0.00203	0.0137	CbGpPWpGaD
Dihydroxyaluminium—Diarrhoea—Rivastigmine—Alzheimer's disease	0.00202	0.00385	CcSEcCtD
Dihydroxyaluminium—Dizziness—Memantine—Alzheimer's disease	0.00199	0.0038	CcSEcCtD
Dihydroxyaluminium—VDAC1—Metabolism of proteins—ACHE—Alzheimer's disease	0.00198	0.0134	CbGpPWpGaD
Dihydroxyaluminium—Nausea—Donepezil—Alzheimer's disease	0.00197	0.00376	CcSEcCtD
Dihydroxyaluminium—Dizziness—Rivastigmine—Alzheimer's disease	0.00195	0.00372	CcSEcCtD
Dihydroxyaluminium—Vomiting—Memantine—Alzheimer's disease	0.00192	0.00366	CcSEcCtD
Dihydroxyaluminium—VDAC1—Metabolism of proteins—CTSD—Alzheimer's disease	0.00188	0.0127	CbGpPWpGaD
Dihydroxyaluminium—Vomiting—Rivastigmine—Alzheimer's disease	0.00187	0.00358	CcSEcCtD
Dihydroxyaluminium—Nausea—Memantine—Alzheimer's disease	0.00179	0.00342	CcSEcCtD
Dihydroxyaluminium—VDAC1—Metabolism of proteins—GSK3A—Alzheimer's disease	0.00176	0.0119	CbGpPWpGaD
Dihydroxyaluminium—Nausea—Rivastigmine—Alzheimer's disease	0.00175	0.00334	CcSEcCtD
Dihydroxyaluminium—VDAC1—Metabolism of proteins—BCHE—Alzheimer's disease	0.00173	0.0117	CbGpPWpGaD
Dihydroxyaluminium—VDAC1—Metabolism of proteins—ACE—Alzheimer's disease	0.00167	0.0113	CbGpPWpGaD
Dihydroxyaluminium—VDAC1—Metabolism of proteins—IGF2—Alzheimer's disease	0.00134	0.00903	CbGpPWpGaD
Dihydroxyaluminium—VDAC1—Metabolism of proteins—LEP—Alzheimer's disease	0.00104	0.00701	CbGpPWpGaD
Dihydroxyaluminium—VDAC1—Metabolism of proteins—F2—Alzheimer's disease	0.000979	0.00661	CbGpPWpGaD
Dihydroxyaluminium—VDAC1—Metabolism of proteins—INS—Alzheimer's disease	0.000887	0.00599	CbGpPWpGaD
Dihydroxyaluminium—VDAC1—Metabolism of proteins—CCL2—Alzheimer's disease	0.000873	0.0059	CbGpPWpGaD
Dihydroxyaluminium—VDAC1—Metabolism of proteins—IGF1—Alzheimer's disease	0.000858	0.0058	CbGpPWpGaD
